Related Experiment Video
Updated: Jul 9, 2025
08:15
In Vitro Cellular Activity Evaluation of the Nanoemulsion Vaccine Adjuvant Ophiopogonin D
Published on: December 9, 2022
1.8K
Biofunctional Inorganic Layered Double Hydroxide Nanohybrid Enhances Immunotherapeutic Effect on Atopic Dermatitis
Min Ji Byun1,2, Hee Seung Seo1,2, Joonghak Lee3
1Department of Biomedical Engineering, SKKU Institute for Convergence, Sungkyunkwan University (SKKU), Suwon, Gyeonggi, 16419, Republic of Korea.
Small (Weinheim an Der Bergstrasse, Germany)
|December 5, 2023
Summary
Indole-3-acetic acid-loaded layered double hydroxides (IAA-LDHs) show promise for treating atopic dermatitis (AD). This novel approach leverages plant hormone properties to reduce inflammation and oxidative stress, offering a potential new therapy for AD.
Area of Science:
- Biomedical Engineering
- Immunology
- Dermatology
Background:
- Atopic dermatitis (AD) is a chronic inflammatory skin disease with significant patient burden.
- Current treatments like corticosteroids have side effects, necessitating novel therapeutic strategies.
- Plant-derived compounds offer potential for anti-inflammatory and antioxidant treatments.
Purpose of the Study:
- To evaluate indole-3-acetic acid-loaded layered double hydroxides (IAA-LDHs) as a novel treatment for atopic dermatitis (AD).
- To investigate the immunomodulatory and antioxidant effects of IAA-LDHs in vitro and in vivo.
Main Methods:
- Synthesis of IAA-LDH nanohybrids.
- Assessment of M2-like macrophage polarization in mouse bone marrow-derived macrophages.
- Quantification of antioxidant activity by measuring intracellular reactive oxygen species (ROS) reduction.
- Evaluation of anti-inflammatory and anti-atopic effects in a mouse model of AD.
Main Results:
- IAA-LDHs successfully induced M2-like macrophage polarization.
- IAA-LDHs demonstrated significant antioxidant activity by reducing ROS levels.
- In vivo studies showed IAA-LDH modulated AD immunology, with positive effects on cutaneous and immunological tissues.
- IAA-LDHs exhibited anti-inflammatory and anti-atopic properties in the AD mouse model.
Conclusions:
- IAA-LDHs possess significant therapeutic potential for atopic dermatitis (AD).
- The nanohybrid formulation enhances macrophage polarization and exhibits antioxidant activity.
- This inorganic drug delivery system offers a promising, safe, and effective alternative for AD treatment.
